Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-31 @ 7:05 PM
Study NCT ID:
NCT03190733
Status:
UNKNOWN
Last Update Posted:
2017-06-19
First Post:
2017-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT
Sponsor:
Zhujiang Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-15
First Submit QC Date:
None
Study First Post Date:
2017-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-15
Last Update Post Date:
2017-06-19
Last Update Post Date Type:
ACTUAL